Yale Medicine doctors: Clinical trials show Pfizer vaccine is 100% effective in ages 12-15

Doctors at Yale Medicine who worked on clinical trials of the Pfizer-BioNTech COVID-19 vaccine say it is shown to be 100% effective and safe for those between the ages of 12 and 15.

News 12 Staff

Mar 31, 2021, 6:57 PM

Updated 1,111 days ago

Share:

Doctors at Yale Medicine who worked on clinical trials of the Pfizer-BioNTech COVID-19 vaccine say it is shown to be 100% effective and safe for those between the ages of 12 and 15.
Dr. Onyema Ogbuagu, who is in charge of COVID-19 clinical studies at Yale Medicine, says that the Pfizer vaccine may be even more effective in young teens than it is in adults.
He says in thousands of patients between the ages of 12 and 16 who received the vaccine, none have contracted COVID-19. Side effects were also comparable to other age groups.
Ogbuagu says the antibody response in the teen group was even stronger than what the vaccine provoked in adults.
The FDA still has to expand Pfizer's emergency use authorization before the vaccine becomes widely available for young teens. Ogbuagu says that approval may come next month.
He says getting young people vaccinated as soon as possible can only make schools safer for in-person learning.
The Pfizer vaccine is in early clinical trials for children 11 and younger.
Researchers say 18 trial participants contracted COVID-19, but all of them had been given the placebo vaccine.
No participants showed a serious adverse reaction.


More from News 12